Analyst Ratings for CTI BioPharma (CTIC) [Buys]
CTIC Rating Summary
CTIC Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$9.07 (-0.3%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 67%
Avg. $ Target:
$9.07 (-0.3%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/1/2022 | Jefferies | Kelly Shi | New Coverage | Buy (N/A) |
13.00 (N/A) |
6.11 (9.09) |
48.77% | Details |
| 7/7/2022 | TD Cowen » Updated 4/17/2023 |
Boris Peaker | New Coverage | Buy (N/A) |
8.00 (10.00) |
6.00 (9.09) |
51.5% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
